Morphic Therapeutic
MORF
$29.56
Share price
2.96%
Change (1 day)
-39.04%
Change (1 year)
Categories
Morphic Therapeutic (MORF) - P/B ratio
P/B ratio as of May 2024 : 2.17
According to Morphic Therapeutic's latest financial reports the company has a price-to-book ratio of 2.17.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Morphic Therapeutic - P/B ratio (from 2019 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 2.06 | -30.23% |
| 2022-12-31 | 2.95 | -43.21% |
| 2021-12-31 | 5.20 | -29.74% |
| 2020-12-31 | 7.40 | 101.9% |
| 2019-12-31 | 3.67 | |
| 2018-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6522 | -69.91% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.96 | -9.62% | 🇺🇸 USA |